94 145

Cited 8 times in

Combination therapy of oral hypoglycemic agents in patients with type 2 diabetes mellitus

 Min Kyong Moon  ;  Kyu Yeon Hur  ;  Seung-Hyun Ko  ;  Seok-O Park  ;  Byung-Wan Lee  ;  Jin Hwa Kim  ;  Sang Youl Rhee  ;  Hyun Jin Kim  ;  Kyung Mook Choi  ;  Nan-Hee Kim  ;  Committee of Clinical Practice Guidelines of the Korean Diabetes Association 
 KOREAN JOURNAL OF INTERNAL MEDICINE, Vol.32(6) : 974-983, 2017 
Journal Title
Issue Date
The Korean Diabetes Association (KDA) recently updated the Clinical Practice Guidelines on antihyperglycemic agent therapy for adult patients with type 2 diabetes mellitus (T2DM). In combination therapy of oral hypoglycemic agents (OHAs), general recommendations were not changed from those of the 2015 KDA guidelines. The Committee on Clinical Practice Guidelines of the KDA has extensively reviewed and discussed the results of meta-analyses and systematic reviews of effectiveness and safety of OHAs and many clinical trials on Korean patients with T2DM for the update of guidelines. All OHAs were effective when added to metformin or metformin and sulfonylurea, although the effects of each agent on body weight and hypoglycemia were different. Therefore, selection of a second agent as a metformin add-on therapy or third agent as a metformin and sulfonylurea add-on therapy should be based on the patient's clinical characteristics and the efficacy, side effects, mechanism of action, risk of hypoglycemia, effect on body weight, patient preference, and combined comorbidity. In this review, we address the results of meta-analyses and systematic reviews, comparing the effectiveness and safety among OHAs. It will help to choose the appropriate drug for an individual patient with T2DM.
Files in This Item:
T201705083.pdf Download
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Lee, Byung Wan(이병완) ORCID logo https://orcid.org/0000-0002-9899-4992
사서에게 알리기


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.